Tech Company Financing Transactions
Affineti Biologics Funding Round
Affineti Biologics, operating out of New Brunswick, secured $500 thousand from Foundation Venture Capital Group.
Transaction Overview
Company Name
Announced On
6/23/2011
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Foundation Venture Capital Group (James Golubieski)
Proceeds Purpose
The company will use the funding to advance its research and development initiatives.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New Brunswick, NJ 08901
USA
New Brunswick, NJ 08901
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
The company uses biological principals to create hybrid or fusion proteins that adhere to tissues with potent but non-toxic antimicrobial effects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Daniel Fine
Browse more venture capital transactions:
Prev: 6/23/2011: WiSpry venture capital transaction
Next: 6/24/2011: Digital Assent venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs